Brief: Tela Bio Posts Quarterly Loss Per Share Of $0.57
Nov 10 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO REPORTS STRONG THIRD QUARTER 2021 REVENUES
REFLECTING
CONTINUED GROWTH DRIVEN BY INCREASED DEMAND
* Q3 REVENUE ROSE 44 PERCENT TO $7.7 MILLION
* MAINTAINING EXPECTATION FOR FY REVENUE TO BE IN RANGE OF
$28.0
MILLION TO $30.0 MILLION
* QTRLY LOSS PER SHARE $0.57
Source text for Eikon: ID:nGNX1LrB9f
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview